Cargando…
Circulating tumor DNA sequencing in colorectal cancer patients treated with first-line chemotherapy with anti-EGFR
Circulating tumor DNA (ctDNA) may reveal dynamic tumor status during therapy. We conducted serial ctDNA analysis to investigate potential association with clinical outcome in metastatic colorectal cancer (mCRC) patients receiving chemotherapy. Tissue KRAS/NRAS wild-type mCRC patients were enrolled a...
Autores principales: | Lim, Yoojoo, Kim, Sheehyun, Kang, Jun-Kyu, Kim, Hwang-Phill, Jang, Hoon, Han, Hyojun, Kim, Hyoki, Kim, Min Jung, Lee, Kyung-Hun, Ryoo, Seung-Bum, Park, Ji Won, Jeong, Seung-Yong, Park, Kyu Joo, Kang, Gyeong Hoon, Han, Sae-Won, Kim, Tae-You |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358023/ https://www.ncbi.nlm.nih.gov/pubmed/34381078 http://dx.doi.org/10.1038/s41598-021-95345-4 |
Ejemplares similares
-
Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer
por: Lee, Dae-Won, et al.
Publicado: (2023) -
Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
por: Lee, Dae-Won, et al.
Publicado: (2019) -
Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer
por: Ryoo, Seung-Bum, et al.
Publicado: (2023) -
Efficacy of Olaparib in Treatment-Refractory, Metastatic Breast Cancer with Uncommon Somatic BRCA Mutations Detected in Circulating Tumor DNA
por: Yoon, Jung-Ki, et al.
Publicado: (2023) -
Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2015)